Compare Ardor (ARDR) vs Enzyme (MLN) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Ardor vs Enzyme — how do they compare? Ardor trades at Rp382.37 (market cap Rp480,7M, Rp15,19M 24h volume), while Enzyme trades at Rp30,212 (market cap Rp134,13M, Rp104,56M 24h volume). The key difference: Ardor is far larger — about 3.6× Enzyme's market cap, and Ardor's supply is capped (998,5M / 998,5M ARDR (100%)) while Enzyme's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Ardor for 21 Days and Enzyme for 28 Days on average.
| ARDR | MLN | |
|---|---|---|
Market Cap | Rp480,7M | Rp134,13M |
Volume (24h) | Rp15,19M | Rp104,56M |
Circulating Supply | 998,5M / 998,5M ARDR (100%) | 3,3M MLN |
Typical Hold Time | 21 Days | 28 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Ardor (ARDR) is trading at Rp402.36 with a market cap of Rp480.7 million, showing a bullish overall signal driven by oscillators while moving averages indicate short-term bearish pressure. The token is fully circulated with a 21-day average hold time. Key technical levels show support near Rp404 and resistance at Rp504. No major protocol updates or ecosystem developments were noted in recent data.
Outlook is cautiously optimistic due to bullish oscillators, but risks include low liquidity and bearish moving averages. Opportunities lie in breaking resistance for upward momentum, while major risks are high volatility and limited market depth. Investors should monitor volume trends and broader crypto market sentiment.
Enzyme (MLN) shows limited market activity with a modest market cap of Rp134.13 million and circulating supply of 3.3 million tokens. The asset demonstrates relatively low volatility with a 28-day average hold time, suggesting stable holding patterns among current investors. Trading volumes appear subdued, indicating limited market participation and liquidity depth at current levels.
Overall outlook remains cautious due to thin liquidity and limited ecosystem developments. Key opportunities include potential protocol upgrades and ecosystem expansion, while major risks center around low trading volumes and regulatory uncertainty in the cryptocurrency space. Investors should monitor network activity and exchange listings for catalysts.
About Ardor
Ardor is a multichain blockchain platform designed with a parent-child chain architecture. The security of the entire network is upheld by the parent Ardor chain, while the interoperable child chains deliver full functionality. The team believes that this architecture, combined with hybrid user permissioning capabilities, provides the necessary flexibility for a wide range of use cases and facilitates the mainstream adoption of blockchain technology.
Read more on ARDR →About Enzyme
Enzyme is an easy-to-use on-chain asset management system that enables access to digital assets and DeFi from one simple, unified app. It provides a front-to-back execution and order management system, which provides fully automated reporting, risk management, administration, governance and operations.
Read more on MLN →
